Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for iRhythm Technologies (IRTC : NSDQ)
 
 • Company Description   
iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.

Number of Employees: 2,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $181.03 Daily Weekly Monthly
20 Day Moving Average: 385,324 shares
Shares Outstanding: 32.13 (millions)
Market Capitalization: $5,816.09 (millions)
Beta: 1.10
52 Week High: $187.57
52 Week Low: $55.92
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 11.68% 9.66%
12 Week 24.39% 12.94%
Year To Date 100.76% 79.25%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
699 8th Street Suite 600
-
San Francisco,CA 94103
USA
ph: 415-632-5700
fax: -
investors@irhythmtech.com http://www.irhythmtech.com
 
 • General Corporate Information   
Officers
Quentin S. Blackford - President and Chief Executive Officer
Abhijit Y. Talwalkar - Chairman
Daniel Wilson - Chief Financial Officer
Marc Rosenbaum - Chief Accounting Officer
Bruce G. Bodaken - Director

Peer Information
iRhythm Technologies (HLIS)
iRhythm Technologies (AZTA)
iRhythm Technologies (APYI)
iRhythm Technologies (RNVA)
iRhythm Technologies (HMSY)
iRhythm Technologies (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 450056106
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 10/29/25
Share - Related Items
Shares Outstanding: 32.13
Most Recent Split Date: (:1)
Beta: 1.10
Market Capitalization: $5,816.09 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.36 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.71 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 33.17% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 10/29/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 56.11
Price/Cash Flow: -
Price / Sales: 8.85
EPS Growth
vs. Year Ago Period: 47.54%
vs. Previous Quarter: 66.32%
Sales Growth
vs. Year Ago Period: 26.10%
vs. Previous Quarter: 17.65%
ROE
06/30/25 - -90.03
03/31/25 - -101.04
12/31/24 - -117.54
ROA
06/30/25 - -8.52
03/31/25 - -9.55
12/31/24 - -11.28
Current Ratio
06/30/25 - 5.02
03/31/25 - 5.71
12/31/24 - 5.82
Quick Ratio
06/30/25 - 4.88
03/31/25 - 5.58
12/31/24 - 5.70
Operating Margin
06/30/25 - -12.09
03/31/25 - -14.23
12/31/24 - -17.48
Net Margin
06/30/25 - -14.06
03/31/25 - -15.90
12/31/24 - -19.14
Pre-Tax Margin
06/30/25 - -13.94
03/31/25 - -15.70
12/31/24 - -19.05
Book Value
06/30/25 - 3.23
03/31/25 - 2.71
12/31/24 - 2.90
Inventory Turnover
06/30/25 - 12.85
03/31/25 - 12.87
12/31/24 - 12.42
Debt-to-Equity
06/30/25 - 6.25
03/31/25 - 7.47
12/31/24 - 7.11
Debt-to-Capital
06/30/25 - 86.21
03/31/25 - 88.19
12/31/24 - 87.67
 

Powered by Zacks Investment Research ©